Amedisys Inc.

NASDAQ: AMED · Real-Time Price · USD
100.99
0.01 (0.01%)
At close: Aug 14, 2025, 3:59 PM
101.00
0.01%
After-hours: Aug 14, 2025, 07:38 PM EDT

Amedisys Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
38.16M -9.75M 117.7M 210.17M
Depreciation & Amortization
60.46M 57.84M 70.96M 71.27M
Stock-Based Compensation
30.64M 29.02M 16.56M 23.81M
Other Working Capital
11.21M -20.66M -95.71M -108.64M
Other Non-Cash Items
45.09M 102.62M 9.73M -29.91M
Deferred Income Tax
7.42M 20.66M 23.38M 44.58M
Change in Working Capital
39.9M -63.21M -105.04M -131.02M
Operating Cash Flow
221.66M 137.19M 133.28M 188.89M
Capital Expenditures
-6.55M -12.71M -7.21M -6.72M
Cash Acquisitions
n/a 47.44M -72.59M -269.96M
Purchase of Investments
n/a n/a -15M -5.2M
Sales Maturities Of Investments
n/a 150K n/a -275K
Other Investing Acitivies
-1.81M -6.9M 318K 554K
Investing Cash Flow
-8.36M 35.06M -94.49M -281.61M
Debt Repayment
n/a -76.01M n/a 239.31M
Common Stock Repurchased
-6.15M -6.53M -25.33M -116.78M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-42.77M -4.98M -5.1M -67.41M
Financial Cash Flow
-48.92M -87.52M -30.43M 55.13M
Net Cash Flow
164.38M 84.73M 8.36M -37.59M
Free Cash Flow
215.12M 124.47M 126.07M 182.17M